A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä
F-18-Labeled Modified Porous Silicon Particles for Investigation of Drug Delivery Carrier Distribution in Vivo with Positron Emission Tomography




Julkaisun tekijät: Sarparanta M, Makila E, Heikkila T, Salonen J, Kukk E, Lehto VP, Santos HA, Hirvonen J, Airaksinen AJ
Kustantaja: AMER CHEMICAL SOC
Julkaisuvuosi: 2011
Journal: Molecular Pharmaceutics
Tietokannassa oleva lehden nimi: MOLECULAR PHARMACEUTICS
Lehden akronyymi: MOL PHARMACEUT
Numero sarjassa: 5
Volyymi: 8
Julkaisunumero: 5
Sivujen määrä: 8
ISSN: 1543-8384

Tiivistelmä
Because of its biocompatibility and ability to accommodate a variety of payloads from poorly soluble drugs to biomolecules, porous silicon (PSi) is a lucrative material for the development of carriers for particle-mediated drug delivery. We report a successful direct one-step F-18-radiolabeling of three types of PSi microparticles, thermally hydrocarbonized THCPSi, thermally oxidized TOPSi, and thermally carbonized TCPSi for the investigation of their biodistribution in vivo with positron emission tomography as part of their evaluation as carriers for particle-mediated drug delivery. FTIR and XPS characterization of the PSI materials after carrier-added F-18/F-19-radiolabeling reveals that depending on the material the F-18-labeling is likely to be accomplished either by substitution for surface silyl hydrogen or silyl fluoride or by nucleophilic attack of F-18(-) to Si-O-Si bridges. With the selected F-18-radiolabeling method, good to excellent in vitro radiolabel stability in simulated gastric and intestinal fluids and in plasma is achieved for all the particle types studied. Finally, a preliminary evaluation of F-18-THCPSi microparticle biodistribution in the rat gastrointestinal tract after oral administration is reported, illustrating the utility of using F-18-radiolabeled PSi as imaging probes for PSi-based drug delivery carrier distribution in vivo.

Last updated on 2019-14-06 at 12:57